Skip to main content

Peer Review reports

From: AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Original Submission
2 Feb 2022 Submitted Original manuscript
3 Feb 2022 Author responded Author comments - Marah G. Chibwana
Resubmission - Version 2
3 Feb 2022 Submitted Manuscript version 2
10 Feb 2022 Reviewed Reviewer Report
15 Feb 2022 Reviewed Reviewer Report
17 Feb 2022 Reviewed Reviewer Report
4 Mar 2022 Author responded Author comments - Marah G. Chibwana
Resubmission - Version 3
4 Mar 2022 Submitted Manuscript version 3
9 Mar 2022 Reviewed Reviewer Report
10 Mar 2022 Reviewed Reviewer Report
11 Mar 2022 Author responded Author comments - Marah G. Chibwana
Resubmission - Version 4
11 Mar 2022 Submitted Manuscript version 4
Publishing
15 Mar 2022 Editorially accepted
28 Mar 2022 Article published 10.1186/s12916-022-02342-z

You can find further information about peer review here.

Back to article page